31st week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200237633 | METHOD FOR HAIR VOLUME REDUCTION | 2020-07-30 |
20200237634 | A CONDITIONING SHAMPOO COMPOSITION | 2020-07-30 |
20200237635 | METHODS FOR TREATING HAIR LOSS DISORDERS | 2020-07-30 |
20200237636 | ANTI-AGING AGENT FOR SKIN AND ANTI-AGING-RELATED GENE EXPRESSION REGULATOR | 2020-07-30 |
20200237637 | N-acyldipeptide Derivatives and Their Uses | 2020-07-30 |
20200237638 | Methods of Reducing or Eliminating Tooth Staining By Application of Stain Barrier Films | 2020-07-30 |
20200237639 | COSMETIC COMPOSITIONS | 2020-07-30 |
20200237640 | Skin Cleansing Compositions Comprising Color Stable Abrasive Particles | 2020-07-30 |
20200237641 | COMPOSITION CONTAINING OLEOSOMES OF DIFFERENT SIZE DISTRIBUTION | 2020-07-30 |
20200237642 | COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | 2020-07-30 |
20200237643 | NOVEL COSMETIC USE OF A NEPHELIUM LAPPACEUM EXTRACT | 2020-07-30 |
20200237644 | COSMETIC MASK FOR APPLICATION TO THE SKIN, AND METHOD FOR APPLYING SAME | 2020-07-30 |
20200237645 | COSMETIC COMPOSITION EFFECTIVE FOR CELL MOISTURIZATION, INTERCELLULAR MOISTURIZATION AND SKIN-BARRIER MOISTURIZATION CONTAINING PLANT EXTRACT | 2020-07-30 |
20200237646 | Sun Block Formulation | 2020-07-30 |
20200237647 | ALTEROMONAS MACLEODII DOW02-2 AND ITS METABOLITES FOR IMPROVING SKIN MOISTURIZATION | 2020-07-30 |
20200237648 | ORALLY ADMINISTRABLE MODIFIED-RELEASED PHARMACEUTICAL DOSAGE FORM | 2020-07-30 |
20200237649 | METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE | 2020-07-30 |
20200237651 | TOPICAL MONTELUKAST FOR TREATMENT OF ATOPIC DERMATITIS | 2020-07-30 |
20200237652 | HEMOPEXIN FORMULATIONS | 2020-07-30 |
20200237653 | LONG-ACTING NON-AQUEOUS INJECTABLE FORMULATIONS AND USE THEREOF | 2020-07-30 |
20200237654 | MICROSTRUCTURE ARRAY, METHODS OF MAKING, AND METHODS OF USE | 2020-07-30 |
20200237655 | LUBRICANT FORMULATIONS | 2020-07-30 |
20200237656 | DRUG DEVICE COMBINATION FOR THE EFFECTIVE TREATMENT OF INCONTINENCE IN WOMEN | 2020-07-30 |
20200237657 | NASAL MOISTURIZER | 2020-07-30 |
20200237658 | CANNABINOID CHEWING GUM WITH IMPROVED RELEASE OF CANNABINOIDS | 2020-07-30 |
20200237659 | CHEWING GUM WITH IMPROVED DELIVERY OF CANNABINOIDS | 2020-07-30 |
20200237660 | CANNABINOID CHEWING GUM WITH POLYVINYL ACETATE ELASTOMER PLASTICIZERS | 2020-07-30 |
20200237661 | CANNABINOID CHEWING GUM WITH HIGH INTENSITY SWEETENERS | 2020-07-30 |
20200237662 | CANNABINOID CHEWING GUM WITH SUGAR ALCOHOLS | 2020-07-30 |
20200237663 | METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS | 2020-07-30 |
20200237664 | Methotrexate Composition | 2020-07-30 |
20200237665 | EMULSIFIED OILS AND BLENDS | 2020-07-30 |
20200237666 | Lecithin Vesicles for Oral Delivery | 2020-07-30 |
20200237667 | A BIODEGRADABLE NANO-THERANOSTIC COMPOSITE AND PROCESS OF PREPARATION THEREOF | 2020-07-30 |
20200237668 | PREPARATION OF DESICCATED LIPOSOMES FOR USE IN COMPRESSIBLE DELIVERY SYSTEMS | 2020-07-30 |
20200237669 | KIDNEY-TARGETING DRUG DELIVERY CARRIER | 2020-07-30 |
20200237670 | DYE-STABILIZED NANOPARTICLES AND METHODS OF THEIR MANUFACTURE AND THERAPEUTIC USE | 2020-07-30 |
20200237671 | Cleavable Lipids | 2020-07-30 |
20200237672 | MINI-TABLETS | 2020-07-30 |
20200237673 | PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2020-07-30 |
20200237674 | DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME | 2020-07-30 |
20200237675 | Systems and Methods for Increasing Stability of Dronabinol Compositions | 2020-07-30 |
20200237676 | COLONIC DRUG DELIVERY FORMULATION | 2020-07-30 |
20200237677 | COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF CARGOS IN VASCULAR PLANTS | 2020-07-30 |
20200237678 | LIPID NANOPARTICLE MEMBRANE COMPOSITION | 2020-07-30 |
20200237679 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS | 2020-07-30 |
20200237680 | NANOFIBER SCAFFOLDS FOR BIOLOGICAL STRUCTURES | 2020-07-30 |
20200237681 | HEMOSTATIC COMPOUND AND PREPARATION METHOD THEREOF | 2020-07-30 |
20200237682 | FAMPRIDINE TTS | 2020-07-30 |
20200237683 | USE OF CANNABIDIOL IN COMBINATION WITH 5-HT2B RECEPTOR AGONISTS OR AMPHETAMINS IN THE TREATMENT OF EPILEPSY | 2020-07-30 |
20200237684 | NOVEL COMPLEXES COMPRISING COLLAGEN PEPTIDES AND CURCUMINOIDS AND COMPOSITIONS THEREOF | 2020-07-30 |
20200237685 | Beta-Hydroxyketones as topical active ingredients for the prevention or treatment of photodermatoses | 2020-07-30 |
20200237686 | AMANTADINE COMPOSITIONS AND METHODS OF USE | 2020-07-30 |
20200237687 | ISOTOPE ENHANCED AMBROXOL FOR LONG LASTING AUTOPHAGY INDUCTION | 2020-07-30 |
20200237688 | VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE | 2020-07-30 |
20200237689 | PREVENTION AND TREATMENT OF CORONAVIRUS AND OTHER RESPIRATORY INFECTIONS USING NANOEMULSION COMPOSITIONS | 2020-07-30 |
20200237690 | ORGANIC COMPOUNDS | 2020-07-30 |
20200237691 | ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE NITRO-CONTAINING AMPHENICOL ANTIBIOTIC SUSCEPTIBILITY | 2020-07-30 |
20200237692 | ANTI-VIRULENCE COMPOSITIONS AND METHODS | 2020-07-30 |
20200237693 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS | 2020-07-30 |
20200237694 | BROAD SPECTRUM PHARMACOLOGICAL COMPOSITION FOR TREATMENT OF VARIOUS INFECTIONS AND DISEASES AND METHODS OF USE | 2020-07-30 |
20200237695 | LEVOTHYROXINE LIQUID FORMULATIONS | 2020-07-30 |
20200237696 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2020-07-30 |
20200237697 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE | 2020-07-30 |
20200237698 | Viral Inhibitor | 2020-07-30 |
20200237699 | METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS | 2020-07-30 |
20200237700 | METHODS OF REDUCING OR PREVENTING OXIDATION OF SMALL DENSE LDL OR MEMBRANE POLYUNSATURATED FATTY ACIDS | 2020-07-30 |
20200237701 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | 2020-07-30 |
20200237702 | CHLOROGENIC ACID COMPOSITION AND METHOD FOR ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | 2020-07-30 |
20200237703 | OLEACEIN FOR USE IN ATHEROSCLEROSIS PREVENTION | 2020-07-30 |
20200237704 | POLYMERIC COMPOSITIONS OF MONOMETHYL FUMARATE AND THEIR USE IN TREATING RELAPSING REMITTING MULTIPLE SCLEROSIS AND PSORIASIS | 2020-07-30 |
20200237705 | METHOD TO TREAT ANTIMICROBIAL RESISTANT CANDIDA | 2020-07-30 |
20200237706 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND/OR PAIN | 2020-07-30 |
20200237707 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING TAXANE | 2020-07-30 |
20200237708 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | 2020-07-30 |
20200237709 | LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC DISORDERS | 2020-07-30 |
20200237710 | SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER | 2020-07-30 |
20200237711 | Compositions for Treating and/or Preventing Cancer | 2020-07-30 |
20200237712 | METHOD OF TREATMENT | 2020-07-30 |
20200237713 | STABLE CANNABINOID COMPOSITIONS | 2020-07-30 |
20200237714 | TRANSDERMAL FORMULATION FOR DELIVERY OF HYDROPHOBIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF | 2020-07-30 |
20200237715 | COX-2 Inhibitors for the Treatment of Ocular Disease | 2020-07-30 |
20200237716 | ALDA-1 TREATMENT AND PREVENTION OF PULMONARY DISEASE | 2020-07-30 |
20200237717 | Treatment of Staphylococcal and Enterococcal Infections Using Substituted Nitrostyrene Compounds | 2020-07-30 |
20200237718 | RTX TOXIN PRODUCTION INHIBITOR AND COMPOSITION FOR TREATING SYMPTOM OF VIBRIO INFECTION BY USING SAME | 2020-07-30 |
20200237719 | NONRACEMIC MIXTURES AND USES THEREOF | 2020-07-30 |
20200237720 | THERAPEUTIC AGENT FOR ALCOHOL USE DISORDERS | 2020-07-30 |
20200237721 | USE OF MAVOGLURANT IN THE REDUCTION OF ALCOHOL USE OR IN PREVENTING RELAPSE INTO ALCOHOL USE | 2020-07-30 |
20200237722 | PREVENTION OR TREATMENT OF DISEASE STATES DUE TO METAL DIS-HOMEOSTASIS VIA ADMINISTRATION OF POSIPHEN TO HEALTHY OR SICK HUMANS | 2020-07-30 |
20200237723 | SODIUM SALT OF N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1 -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDE | 2020-07-30 |
20200237724 | ADRENERGIC RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING THE SAME | 2020-07-30 |
20200237725 | SHMT Inhibitors | 2020-07-30 |
20200237726 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS | 2020-07-30 |
20200237727 | USE OF ISOXAZOLINE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF ARTHROPOD INFESTATIONS IN POULTRY | 2020-07-30 |
20200237728 | CHEMOTHERAPEUTIC METHODS | 2020-07-30 |
20200237729 | 5-SUBSTITUTED 2,4-THIAZOLIDINEDIONES (THIOHYDANTOINS). PSEUDOTHIOHYDANTOINS, AND PROPSEUDOTHIOHYDANTOINS FOR USE AS ANTIVIRAL AGENTS | 2020-07-30 |
20200237730 | NOVEL DOSAGE PRINCIPLE FOR DRUGS USEFUL FOR TREATING NEOPLASTIC DISEASES | 2020-07-30 |
20200237731 | USE OF CLOXACILLIN TO INHIBIT/PREVENT BIOFILM FORMATION | 2020-07-30 |
20200237732 | TOPICAL COMPOSITIONS OF DUTASTERIDE | 2020-07-30 |
20200237733 | PHARMACEUTICAL PREPARATION | 2020-07-30 |